News und Analysen
Can Unity Software Sustain The Momentum?
Unity Software (NYSE: U) broke above a critical resistance level last week. The stock, now up 55% year-to-date, looks set to continue its impressive momentum on the year after last week's action
Is the Microsoft Deal Driving Applied Optoelectronics 300% Gain?
It’s highly unlikely you’ve heard of Applied Optoelectronics Inc. (NASDAQ: AAOI) until maybe recently, as shares soared more than 300% on its new supply agreement with Microsoft Co. (NASDAQ: MSFT)
Investors Like Adobe's Potential To Leverage Generative AI
A few decades ago, a comedian named Murray Langston made a splash with an alter ego he dubbed “the unknown comic.” Langson was funny, but nobody knew who he was, since he performed with a bag over
Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. 204% Biotech Hot Stock nach 134.452% mit Biogen
17.07.23 08:03
London (www.aktiencheck.de , Anzeige)
Investing in Blue Chip Stocks: A Guide to Stability and Growth
Investors who are looking for stability and steady growth often turn toward blue chip stocks. Blue chip stocks are shares in large, well-established companies with a history of reliable performance
Fastenal Falls To The Buy Zone: But Wait To Buy More
Fastenal (NASDAQ: FAST) fell following its Q2 earnings release and could fall further. The caveat is that tepid results do not overshadow the company’s strengths, including a solid balance sheet
Broadcom Emerges As Strong Contender For Generative AI Chips
So far in the AI gold rush, Nvidia Corp. (NASDAQ: NVDA) has emerged as the leading chipmaker. However, analysts and investors are beginning to notice the potential for Broadcom Inc. (NASDAQ: AVGO)
Will Cintas Scale a New High in 2023?
Despite its already-high valuation, Cintas (NASDAQ: CTAS) can scale new highs in 2023. Its FQ4 results and guidance confirm the business trajectory's growing and widening margin.
As highly
Eilt: Hautkrebs-Studie mit sensationellen Ergebnissen - Massives Kaufsignal. Neuer 204% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Hautkrebs-Studie mit sensationellen Ergebnissen - Massives Kaufsignal. 204% Biotech Aktientip nach 15.973% mit BioNTech
14.07.23 08:02
London (www.aktiencheck.de , Anzeige)
PepsiCo Can Soar To New Highs In The 2nd Half
PepsiCo (NASDAQ: PEP) has been leading the beverage and consumer staples market for years, and the company is unlikely to lose its position. The Q2 results prove the pep+ strategy is working and
3 Biotech Stocks to Buy for Long-Term Gains
Suppose you’re looking for a sector that will benefit from an end to the Federal Reserve’s interest rate hiking campaign. In that case, you may look at biotech stocks, a sector filled with
Netflix Can Soar Higher In The 2nd Half
Netflix (NASDAQ: NFLX) made some big changes over the last year, but the signs are good that those changes are working for the better. The combination of password-sharing initiatives and
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 206% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 206% mit Biotech Hot Stock
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. 206% Biotech Aktientip nach 134.452% mit Biogen
13.07.23 08:18
London (www.aktiencheck.de, Anzeige)
Activision Surges 10% As Judge OK's Microsoft Acquisition Deal
Activision Blizzard Inc. (NASDAQ: ATVI) shares rose to the call of duty on July 11, advancing 10.02% in heavy trading volume as a federal judge gave the OK for Microsoft Corp. (NASDAQ: MSFT) to
Erstklassige Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 208% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Erstkl. Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. 208% Biotech Hot Stock nach 31.205% mit Amgen
12.07.23 08:02
London (www.aktiencheck.de, Anzeige)
Pullback Creates an Opportunity for ‘The Amazon of Latin America'
Latin American e-commerce leader MercadoLibre, Inc. (NASDAQ:MELI) surpassed consensus earnings estimates in each of the last five quarters. This includes a resounding 42% first quarter beat that
Is Samsung's Warning Of A Chip Glut Hurting DRAM Maker Micron?
Remember the pandemic-era chip shortage? Well, that’s history now, and there’s currently a chip glut, according to Samsung Electronics Co., Ltd. (OTCMKTS: SSNLF), which warned that its profit
Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. Erstklassige Studienergebnisse. Massives Kaufsignal. Neuer 208% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Bi
Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs - Massives Kaufsignal. 208% Biotech Aktientip nach 134452%
11.07.23
London (www.aktiencheck.de, Anzeige)
Meta Threads Its Way To New Heights
Meta (NASDAQ: META) took the tech world by storm again with its Threads announcement. Threads is a new app built by the Instagram team that allows functionality akin to Twitter. Users log in using
The 3 Hot Sectors To Watch During The Summer Reporting Season
Market participants may have positioned in May and gone away, but the analysts have remained active. They continue to update the earnings outlook, and the first few reports from S&P 500 (NYSEARCA:
Can ChatGPT AI Revitalize Microsoft's Bing Search Engine?
Technology provider Microsoft Co. (NYSE: MSFT) has garnered much of the spotlight in mainstream artificial intelligence (AI) adoption in 2023. Open.ai’s launch of ChatGPT kicked off the AI mania
Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi
Stocks often react differently from the way you think they might. That happened on July 7 as shares of Biogen Inc. (NASDAQ: BIIB) swooned 2.88% in heavy trading volume following news of full
Enphase Energy is Still Converting Solar Energy into Profits
Solar energy products maker Enphase (NYSE: ENPH) stock has fallen from grace after hitting all-time highs near $340 in December 2022, losing more than half its value by July 2023. The company was
Why Buying The Dip In Alphabet (Google) Could Yield Big Returns
Alphabet shares (NASDAQ: GOOGL) are finding support at a previous area of resistance, pointing toward a potential upside in the stock if buyers can continue to stand firm. On the year, shares of
EV Mixed Signals: Sales Are Rising, But Inventory Slower To Move
Sales of electric vehicles are continuing to grow, but at a slower pace, according to Cox Automotive, which provides marketing and financing services to the auto industry.
The EV industry is